Nick Mordwinkin
Corporate Officer/Principal en KEZAR LIFE SCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Nick Mordwinkin was the founder of Curium, a company founded in 2014, where he held the title of President from 2014 to 2016.
He is currently the Chief Business Officer at Kezar Life Sciences, Inc. since 2022.
Previously, he worked at Ultragenyx Pharmaceutical, Inc. from 2015 to 2020 as the Senior Director & Head-Corporate Strategy.
From 2020 to 2022, he was the Head-Development, Inflammation & Fibrosis at Gilead Sciences, Inc. Dr. Mordwinkin holds a doctorate degree from the University of Southern California and an undergraduate degree from Nova Southeastern University, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 07/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Nick Mordwinkin
| Empresas | Cargo | Inicio |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 11/07/2022 |
Antiguos cargos conocidos de Nick Mordwinkin.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/10/2020 |
| Curium | Founder | 01/12/2016 |
Formación de Nick Mordwinkin.
| University of Southern California | Doctorate Degree |
| Nova Southeastern University, Inc. | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Curium |
- Bolsa de valores
- Insiders
- Nick Mordwinkin
